We use structural, chemical and molecular biology approaches along with medicinal chemistry and high-throughput screening, to identify and validate novel therapeutic targets.
Our work has relevance to a range of diseases including cancers, inflammatory diseases and infections.
Members of our division have made important contributions to a number of research areas, including our understanding of:
- cell death pathways
- kinase signalling pathways
- protein glycosylation in diseases
- the molecular mechanisms that contribute to malarial parasite survival
To contact the division please email Leeanne Lewis, Division Coordinator, at lewis.l@wehi.edu.au
